List of Publications

1.   Bhatia, S.N., Chen, X., Dobrovolskaia, M.A., Lammers, T. (2022) Cancer nanomedicine. Nature Reviews Cancer, 22(10), 550-556. doi:10.1038/s41568-022-00496-9

2.   Liu, C., Liu, X., Xiang, X., Pang, X., Chen, S., Zhang, Y., Ren, E., Zhang, L., Liu, X., Lv, P., Wang, X., Luo, W., Xia, N., Chen, X., Liu, G. (2022)A nanovaccine for antigen self-presentation and immunosuppression reversal as a personalized cancer immunotherapy strategy. Nature Nanotechnology ,17(5), 531-540. doi:10.1038/s41565-022-01098-0

3.   Mu, J., Xiao, M., Shi, Y., Geng, X., Li, H., Yin, Y., Chen, X. (2022) The Chemistry of Organic Contrast Agents in the NIR-II Window. Angewandte Chemie - International Edition, 61(14). doi:10.1002/anie.202114722

4.   Baum, R.P., Schuchardt, C., Singh, A., Chantadisai, M., Robiller, F.C., Zhang, J., Mueller, D., Eismant, A., Almaguel, F., Zboralski, D., Osterkamp, F., Hoehne, A., Reineke, U., Smerling, C., Kulkarni, H.R. (2022) Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using 177Lu-FAP-2286: First-in-Humans Results. Journal of Nuclear Medicine, 63(3), 415-423. doi:10.2967/jnumed.120.259192

5.   Zeng, F., Tang, L., Zhang, Q., Shi, C., Huang, Z., Nijiati, S., Chen, X., Zhou, Z. (2022) Coordinating the Mechanisms of Action of Ferroptosis and the Photothermal Effect for Cancer Theranostics. Angewandte Chemie - International Edition, 61(13). doi:10.1002/anie.202112925

6.   Wang, Z., Sun, C., Yang, K., Chen, X., Wang, R. (2022) Cucurbituril-Based Supramolecular Polymers for Biomedical Applications. Angewandte Chemie - International Edition, 61(38). doi:10.1002/anie.202206763

7.   Wang, X., Sun, W., Shi, H., Ma, H., Niu, G., Li, Y., Zhi, J., Yao, X., Song, Z., Chen, L., Li, S., Yang, G., Zhou, Z., He, Y., Qu, S., Wu, M., Zhao, Z., Yin, C., Lin, C., Gao, J., Li, Q., Zhen, X., Li, L., Chen, X., Liu, X., An, Z., Chen, H., Huang, W. (2022) Organic phosphorescent nanoscintillator for low-dose X-ray-induced photodynamic therapy. Nature Communications, 13(1). doi:10.1038/s41467-022-32054-0

8.   Wu, D., Yang, K., Zhang, Z., Feng, Y., Rao, L., Chen, X., Yu, G. (2022) Metal-free bioorthogonal click chemistry in cancer theranostics. Chemical Society Reviews, 51(4), 1336-1373. doi:10.1039/d1cs00451d

9.   Schuchardt, C., Zhang, J., Kulkarni, H.R., Chen, X., Müller, D., Baum, R.P. (2022) Prostate-Specific Membrane Antigen Radioligand Therapy Using 177Lu-PSMA I&T and 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer: Comparison of Safety, Biodistribution, and Dosimetry. Journal of Nuclear Medicine, 63(8), 1199-1207. doi:10.2967/JNUMED.121.262713

10.   Ma, Y., Su, Z., Zhou, L., He, L., Hou, Z., Zou, J., Cai, Y., Chang, D., Xie, J., Zhu, C., Fan, W., Chen, X., Ju, S. (2022) Biodegradable Metal–Organic-Framework-Gated Organosilica for Tumor-Microenvironment-Unlocked Glutathione-Depletion-Enhanced Synergistic Therapy. Advanced Materials, 34(12). doi:10.1002/adma.202107560

11.   Yang, K., Yang, Z., Yu, G. Nie, Z., Wang, R., Chen, X. (2022) Polyprodrug Nanomedicines: An Emerging Paradigm for Cancer Therapy. Advanced Materials, 34(6). doi:10.1002/adma.202107434

12.   Zhang, Z., Dalan, R., Hu, Z., Wang, J.-W., Chew, N.W.S., Poh, K.-K., Tan, R.-S., Soong, T.W., Dai, Y., Ye, L., Chen, X. (2022) Reactive Oxygen Species Scavenging Nanomedicine for the Treatment of Ischemic Heart Disease. Advanced Materials, 34(35). doi:10.1002/adma.202202169

13.   Hou, L., Gong, X., Yang, J., Zhang, H., Yang, W., Chen, X. (2022) Hybrid-Membrane-Decorated Prussian Blue for Effective Cancer Immunotherapy via Tumor-Associated Macrophages Polarization and Hypoxia Relief. Advanced Materials, 34(14). doi:10.1002/adma.202200389

14.   Hu, H., Zhong, D., Li, W., Lin, X., He, J., Sun, Y., Wu, Y., Shi, M., Chen, X., Xu, F., Zhou, M. (2022) Microalgae-based bioactive hydrogel loaded with quorum sensing inhibitor promotes infected wound healing. Nano Today, 42. doi:10.1016/j.nantod.2021.101368

15.   Wen, X., Xu, P., Shi, M., Liu, J., Zeng, X., Zhang, Y., Shi, C., Li, J., Guo, Z., Zhang, X., Khong, P.-L., Chen, X. (2022) Evans blue-modified radiolabeled fibroblast activation protein inhibitor as long-acting cancer therapeutics. Theranostics, 12(1), 422-433. doi:10.7150/thno.68182

16.   Li, B., Zhao, M., Lin, J., Huang, P., Chen, X. (2022) Management of fluorescent organic/inorganic nanohybrids for biomedical applications in the NIR-II region. Chemical Society Reviews, 51(18), 7692-7714. doi:10.1039/d2cs00131d

17.   Pan, Y., Zhu, Y., Xu, C., Pan, C., Shi, Y., Zou, J., Li, Y., Hu, X., Zhou, B., Zhao, C., Gao, Q., Zhang, J., Wu, A., Chen, X., Li, J. (2022) Biomimetic Yolk-Shell Nanocatalysts for Activatable Dual-Modal-Image-Guided Triple-Augmented Chemodynamic. Therapy of Cancer ACS Nano, 16 (11), 19038-19052. doi:10.1021/acsnano.2c08077

18.   Wu, S.-Y., Wu, F.-G., Chen, X. (2022) Antibody-Incorporated Nanomedicines for Cancer. Therapy Advanced Materials, 34(24). doi:10.1002/adma.202109210

19.   Mu, J., Li, C., Shi, Y., Liu, G., Zou, J., Zhang, D.-Y., Jiang, C., Wang, X., He, L., Huang, P., Yin, Y., Chen, X. (2022) Protective effect of platinum nano-antioxidant and nitric oxide against hepatic ischemia-reperfusion injury. Nature Communications,13(1). doi:10.1038/s41467-022-29772-w

20.   Tian, R., Feng, X., Wei, L., Dai, D., Ma, Y., Pan, H., Ge, S., Bai, L., Ke, C., Liu, Y., Lang, L., Zhu, S., Sun, H., Yu, Y., Chen, X. (2022) A genetic engineering strategy for editing near-infrared-II fluorophores. Nature Communications,13(1). doi:10.1038/s41467-022-30304-9

21.   Pan, Y., Tang, W., Fan, W., Zhang, J., Chen, X. (2022) Development of nanotechnology-mediated precision radiotherapy for anti-metastasis and radioprotection. Chemical Society Reviews, 51(23), 9759-9830. doi:10.1039/d1cs01145f

22.   Huang, P., Deng, H., Zhou, Y., Chen, X. (2022) The roles of polymers in mRNA delivery. Matter, 5(6), 1670-1699. doi:10.1016/j.matt.2022.03.006

23.   Li, B., Liu, H., He, Y., Zhao, M., Ge, C., Younis, M.R., Huang, P., Chen, X., Lin, J. (2022) A “Self-Checking” pH/Viscosity-Activatable NIR-II Molecule for Real-Time Evaluation of Photothermal Therapy Efficacy. Angewandte Chemie - International Edition, 61(16). doi:10.1002/anie.(2022)00025

24.   Zhao, C., Pang, X., Yang, Z., Wang, S., Deng, H., Chen, X. (2022) Nanomaterials targeting tumor associated macrophages for cancer immunotherapy. Journal of Controlled Release 341, 272-284. doi:10.1016/j.jconrel.2021.11.028

25.   Hua, Y., Huang, J.-H., Shao, Z.-H., Luo, X.-M., Wang, Z.-Y., Liu, J.-Q., Zhao, X., Chen, X., Zang, S.-Q. (2022) Composition-Dependent Enzyme Mimicking Activity and Radiosensitizing Effect of Bimetallic Clusters to Modulate Tumor Hypoxia for Enhanced Cancer Therapy. Advanced Materials, 34 (31). doi:10.1002/adma.(2022)03734

26.   Deng, H., Yang, Z., Pang, X., Zhao, C., Tian, J., Wang, Z., Chen, X. (2022) Self-sufficient copper peroxide loaded pKa-tunable nanoparticles for lysosome-mediated chemodynamic therapy. Nano Today, 42. doi:10.1016/j.nantod.2021.101337

27.   Zang, J., Wen, X., Lin, R., Zeng, X., Wang, C., Shi, M., Zeng, X., Zhang, J., Wu, X., Zhang, X., Miao, W., Xu, P., Guo, Z., Zhang, J., Chen, X. (2022) Synthesis, preclinical evaluation and radiation dosimetry of a dual targeting PET tracer [68Ga]Ga-FAPI-RGD. Theranostics, 12(16), 7180-7190. doi:10.7150/thno.79144

28.   Bai, L., Hu, Z., Han, T., Wang, Y., Xu, J., Jiang, G., Feng, X., Sun, B., Liu, X., Tian, R., Sun, H., Zhang, S., Chen, X., Zhu, S. (2022) Super-stable cyanine@albumin fluorophore for enhanced NIR-II bioimaging. Theranostics, 12(10) 4536-4547. doi:10.7150/thno.71443

29.   Mo, T., Liu, X., Luo, Y., Zhong, L., Zhang, Z., Li, T., Gan, L., Liu, X., Li, L., Wang, H., Sun, X., Fan, D., Qian, Z., Wu, P., Chen, X. (2022) Aptamer-based biosensors and application in tumor theranostics. Cancer Science, 113, 1 7-16. doi:10.1111/cas.15194

30.   Pan, Y., Xu, C., Deng, H., You, Q., Zhao, C., Li, Y., Gao, Q., Akakuru, O.U., Li, J., Zhang, J., Wu, A., Chen, X. (2022) Localized NIR-II laser mediated chemodynamic therapy of glioblastoma. Nano Today, 43. doi:10.1016/j.nantod.2022.101435

31.   An, L., Wang, C., Tian, Q., Tao, C., Xue, F., Yang, S., Zhou, X., Chen, X., Huang, G. (2022) NIR-II laser-mediated photo-Fenton-like reaction via plasmonic Cu9S8 for immunotherapy enhancement. Nano Today, 43. doi:10.1016/j.nantod.2022.101397

32.   Zhao, C., Deng, H., Chen, X. (2022) Harnessing immune response using reactive oxygen Species-Generating/Eliminating inorganic biomaterials for disease treatment. Advanced Drug Delivery Reviews, 188. doi:10.1016/j.addr.2022.114456

33.   He, J., Hua, S., Zhang, D., Wang, K., Chen, X., Zhou, M. (2022) SERS/NIR-II Optical Nanoprobes for Multidimensional Tumor Imaging from Living Subjects, Pathology, and Single Cells and Guided NIR-II Photothermal. Therapy Advanced Functional Materials, 32(46). doi:10.1002/adfm.202208028

34.   Ye, Y., He, J., Wang, H., Li, W., Wang, Q., Luo, C., Tang, X., Chen, X., Jin, X., Yao, K., Zhou, M. (2022) Cell Wall Destruction and Internal Cascade Synergistic Antifungal Strategy for Fungal Keratitis ACS Nano 16 11 18729-18745 doi:10.1021/acsnano.2c07444

35.   Xue, Y., Che, J., Ji, X., Li, Y., Xie, J., Chen, X. (2022) Recent advances in biomaterial-boosted adoptive cell therapy. Chemical Society reviews, 51(5), 1766-1794 doi:10.1039/d1cs00786f

36.   He, P., Ren, E., Chen, B., Chen, H., Cheng, H., Gao, X., Liang, X., Liu, H., Li, J., Li, B., Chen, A., Chu, C., Chen, X., Mao, J., Zhang, Y., Liu, G. (2022) A super-stable homogeneous Lipiodol-hydrophilic chemodrug formulation for treatment of hepatocellular carcinoma. Theranostics, 12(4), 1769-1782. doi:10.7150/thno.68456

37.   Huang, X., Zha, F., Zou, J., Li, Y., Wang, F., Chen, X. (2022) Photoacoustic Imaging-Guided Synergistic Photothermal/Radiotherapy Using Plasmonic Bi/Bi2O3−x Nanoparticles. Advanced Functional Materials, 32(23). doi:10.1002/adfm.202113353

38.   Chan, C.Y.-K., Chiu, D.K.-C., Yuen, V.W.-H., Law, C.-T., Wong, B.P.-Y., Thu, K.L., Cescon, D.W., Soria-Bretones, I., Cheu, J.W.-S., Lee, D., Tse, A.P.-W., Zhang, M.S., Tan, K.V., Ng, I.O.-L., Khong, P.-L., Yau, T.C.-C., Bray, M.R., Mak, T.W., Wong, C.C.-L. (2022) CFI-402257, a TTK inhibitor, effectively suppresses hepatocellular carcinoma. Proceedings of the National Academy of Sciences of the United States of America, 119(32). doi:10.1073/pnas.2119514119

39.   Li, L., Chen, X., Yu, J., Yuan, S. (2022)Preliminary Clinical Application of RGD-Containing Peptides as PET Radiotracers for Imaging Tumors. Frontiers in Oncology, 12. doi:10.3389/fonc.2022.837952

40.   Meng, L., Fang, J., Zhao, L., Wang, T., Yuan, P., Zhao, Z., Zhuang, R., Lin, Q., Chen, H., Chen, X., Zhang, X., Guo, Z. (2022) Rational Design and Pharmacomodulation of Protein-Binding Theranostic Radioligands for Targeting the Fibroblast Activation Protein. Journal of Medicinal Chemistry, 65(12), 8245-8257. doi:10.1021/acs.jmedchem.1c02162

41.   Shi, M., Jakobsson, V., Greifenstein, L., Khong, P.-L., Chen, X., Baum, R.P., Zhang, J. (2022) Alpha-peptide receptor radionuclide therapy using actinium-225 labeled somatostatin receptor agonists and antagonists. Frontiers in Medicine, 9. doi:10.3389/fmed.2022.1034315

42.   Severn, C., Suresh, K., Görg, C., Choi, Y.S., Jain, R., Ghosh, D. (2022) A Pipeline for the Implementation and Visualization of Explainable Machine Learning for Medical Imaging Using Radiomics Features. Sensors, 22(14). doi:10.3390/s22145205

43.   Li, Q., Xu, R., Fan, H., Xu, J., Xu, Y., Cao, P., Zhang, Y., Liang, T., Zhang, Y., Chen, W., Wang, Z., Wang, L., Chen, X. (2022) Smart Mushroom-Inspired Imprintable and Lightly Detachable (MILD) Microneedle Patterns for Effective COVID-19 Vaccination and Decentralized Information Storage. ACS Nano, 16(5), 7512-7524. doi:10.1021/acsnano.1c10718

44.   Zhao, M., Zhuang, H., Zhang, H., Li, B., Ming, J., Chen, X., Chen, M. (2022) A LRET Nanoplatform Consisting of Lanthanide and Amorphous Manganese Oxide for NIR-II Luminescence Lifetime Imaging of Tumor Redox Status. Angewandte Chemie - International Edition, 61(47). doi:10.1002/anie.202209592

45.   Wen, X., Shi, C., Zeng, X., Zhao, L., Yao, L., Liu, Z., Feng, L., Zhang, D., Huang, J., Li, Y., Lin, Q., Chen, H., Zhuang, R., Chen, X., Zhang, X., Guo, Z. (2022) A Paradigm of Cancer Immunotherapy Based on 2-[18F]FDG and Anti-PD-L1 mAb Combination to Enhance the Antitumor Effect. Clinical cancer research : an official journal of the American Association for Cancer Research, 28(13), 2923-2937. doi:10.1158/1078-0432.CCR-22-0159

46.   Wen, X., Zeng, X., Cheng, X., Zeng, X., Liu, J., Zhang, Y., Li, Y., Chen, H., Huang, J., Guo, Z., Chen, X., Zhang, X. (2022) PD-L1-Targeted Radionuclide Therapy Combined with αpD-L1 Antibody Immunotherapy Synergistically Improves the Antitumor Effect. Molecular Pharmaceutics, 19(10), 3612-3622. doi:10.1021/acs.molpharmaceut.2c00281

47.   Chen, W., Wang, Z., Wang, L., Chen, X. (2022) Smart Chemical Engineering-Based Lightweight and Miniaturized Attachable Systems for Advanced Drug Delivery and Diagnostics. Advanced Materials, 34(6). doi:10.1002/adma.202106701

48.   Pan, Y., Liu, L., Rao, L., Chen, X. (2022) Nanomaterial-mediated ablation therapy for cancer stem cells. Matter, 5(5), 1367-1390. doi:10.1016/j.matt.2022.02.015

49.   Cui, C., Wang, C., Fu, Q., Song, J., Zou, J., Li, L., Zhu, J., Huang, W., Li, L., Yang, Z., Chen, X. (2022) A generic self-assembly approach towards phototheranostics for NIR-II fluorescence imaging and phototherapy. Acta Biomaterialia, 140, 601-609. doi:10.1016/j.actbio.2021.11.023

50.   Li, M., Zheng, X., Han, T., Ma, S., Wang, Y., Sun, B., Xu, J., Wang, X., Zhang, S., Zhu, S., Chen, X. (2022) Near-infrared-II ratiometric fluorescence probes for non-invasive detection and precise navigation surgery of metastatic sentinel lymph nodes. Theranostics, 12(16), 7191-7202. doi:10.7150/thno.78085

51.   Hong, F., Geng, X., Min, G., Sun, X., Zhang, B., Yao, Y., Li, R., Wang, J., Zhao, H., Guo, P., Yuan, Z., Wen, X., Nie, L., Liu, G., Chen, X., Zhao, Q. (2022) Deep NIR-II optical imaging combined with minimally invasive interventional photothermal therapy for orthotopic bladder cancer. Chemical Engineering Journal, 449. doi:10.1016/j.cej.2022.137846

52.   Zhao, L., Pang, Y., Wang, Y., Chen, J., Zhuang, Y., Zhang, J., Zhao, L., Sun, L., Wu, H., Chen, X., Lin, Q., Chen, H. (2022) Somatostatin receptor imaging with [68Ga]Ga-DOTATATE positron emission tomography/computed tomography (PET/CT) in patients with nasopharyngeal carcinoma. European Journal of Nuclear Medicine and Molecular Imaging, 49(4), 1360-1373. doi:10.1007/s00259-021-05587-7

53.   Yang, W., Zhang, M., Zhang, J., Liu, Y., Ning, J., Yang, J., Zhang, Z., Hou, L., Chen, X. (2022) In vivo activated T cell targeting with PD-1/PD-L1 blockade for sequential treatment mediated cancer immunotherapy. Nano Today, 44. doi:10.1016/j.nantod.2022.101492

54.   Wang, G., Zhou, M., Zang, J., Jiang, Y., Chen, X., Zhu, Z., Chen, X. (2022) A pilot study of 68 Ga-PSMA-617 PET/CT imaging and 177Lu-EB-PSMA-617 radioligand therapy in patients with adenoid cystic carcinoma. EJNMMI Research, 12(1). doi:10.1186/s13550-022-00922-x

55.   Jiang, Y., Liu, Q., Wang, G., Sui, H., Wang, R., Wang, J., Zhang, J., Zhu, Z., Chen, X. (2022) Safety and efficacy of peptide receptor radionuclide therapy with 177Lu-DOTA-EB-TATE in patients with metastatic neuroendocrine tumors. Theranostics, 12(15), 6437-6445. doi:10.7150/thno.77219

56.   Wu, J., Tian, J., Zhang, Y., Ji, H., Sun, J., Wang, X., Sun, C., Wang, L., Teng, Z., Lu, G., Zhu, H., Chen, X. (2022) 18F-Alfatide II for the evaluation of axillary lymph nodes in breast cancer patients: comparison with 18F-FDG European Journal of Nuclear Medicine and Molecular Imaging 49 8 2869-2876 doi:10.1007/s00259-021-05333-z

57.   Chan, S.Y., Ong, Z.Y., Ngoh, Z.M., Chong, Y.S., Zhou, J.H., Fortier, M.V., Daniel, L.M., Qiu, A., Meaney, M.J., Tan, A.P. (2022) Structure-function coupling within the reward network in preschool children predicts executive functioning in later childhood. Developmental Cognitive Neuroscience, 55. doi:10.1016/j.dcn.2022.101107

58.   Duan, H., Ma, T., Huang, X., Gao, B., Zheng, L., Chen, X., Xiong, Y., Chen, X. (2022) Avoiding the self-nucleation interference: a pH-regulated gold in situ growth strategy to enable ultrasensitive immunochromatographic diagnostics. Theranostics, 12(6), 2801-2810. doi:10.7150/thno.70092

59.   Kang, X., Wang, Y., Cai, X.-L., Hua, Y., Shao, Z.-H., Chen, X., Zhao, X., Zang, S.-Q. (2022) Chiral gold clusters functionalized two-dimensional nanoparticle films to regulate the adhesion and differentiation of stem cells. Journal of Colloid and Interface Science, 625, 831-838. doi:10.1016/j.jcis.2022.06.070

60.   Lu, Y., Feng, J., Liang, Z., Lu, X., Guo, S., Huang, L., Xiong, W., Chen, S., Zhou, H., Ma, X., Xu, Y., Qiu, X., Wu, A., Chen, X., Shen, Z. (2022) A tumor microenvironment dual responsive contrast agent for contrary contrast-magnetic resonance imaging and specific chemotherapy of tumors. Nanoscale Horizons, 7(4), 403-413. doi:10.1039/d1nh00632k

61.   Li, B., Lin, J., Huang, P., Chen, X. (2022) Near-infrared probes for luminescence lifetime imaging. Nanotheranostics, 6(1), 91-102. doi:10.7150/ntno.63124

62.   Wen, X., Zeng, X., Liu, J., Zhang, Y., Shi, C., Wu, X., Zhuang, R., Chen, X., Zhang, X., Guo, Z. (2022)Synergism of 64Cu-Labeled RGD with Anti-PD-L1 Immunotherapy for the Long-Acting Antitumor Effect. Bioconjugate Chemistry, 33(11), 2170-2179. doi:10.1021/acs.bioconjchem.2c00408

63.   Ni, Q., Chen, X. (2022) Current challenges and potential directions towards nanotechnology in medicine and transformation. Nano TransMed, 1(2-4). doi:10.26599/NTM.2022.9130011

64.   Qiu, Q., Huang, Y., Zhang, B., Huang, D., Chen, X., Fan, Z., Lin, J., Yang, W., Wang, K., Qu, N., Li, J., Li, Z., Huang, J., Li, S., Zhang, J., Liu, G., Rui, G., Chen, X., Zhao, Q. (2022) Noninvasive Dual-Modality Photoacoustic-Ultrasonic Imaging to Detect Mammalian Embryo Abnormalities after Prenatal Exposure to Methylmercury Chloride (MMC): A Mouse Study. Environmental Health Perspectives, 130(2). doi:10.1289/EHP8907

65.   Zhang, M., Ye, J., Xie, Z., Wang, Y., Ma, W., Kang, F., Yang, W., Wang, J., Chen, X. (2022) Combined Probe Strategy to Increase the Enzymatic Digestion Rate and Accelerate the Renal Radioactivity Clearance of Peptide Radiotracers. Molecular Pharmaceutics, 19(5), 1548-1556. doi:10.1021/acs.molpharmaceut.2c00051

66.   Wu, J., Zhang, X., Jia, Z., Zhou, X., Qi, R., Ji, H., Sun, J., Sun, C., Teng, Z., Lu, G., Chen, X. (2022) Combined 18F-FDG and 18F-Alfatide II PET May Predict Luminal B (HER2 Negative) Subtype and Nonluminal Subtype of Invasive Breast Cancer. Molecular Pharmaceutics, 19(9), 3405-3411. doi:10.1021/acs.molpharmaceut.2c00547

67.   Zhang, Y., Li, J., Liu, C., Zheng, K., Zhang, B., Zhou, Y., Dai, C., Fan, S., Yao, Y., Zhuang, R. Guo, D., Huang, Z., Mao, J., Liang, J., Yang, H., Wang, L., Liu, G., Chen, X., Zhao, Q. (2022) Development of a multi-scene universal multiple wavelet-FFT algorithm (MW-FFTA) for denoising motion artifacts in OCT-angiography in vivo imaging. Optics Express, 30(20), 35854-35870. doi:10.1364/OE.465255

68.   Wang, Y., Hua, Y., Shao, Z.-H., Chen, X., Zhao, X., Zang, S.-Q. (2022) Levonorgestrel-protected Au8 and Au10 clusters with different antimicrobial abilities. Journal of Materials Chemistry B, 10(26), 5028-5034. doi:10.1039/d2tb00533f

69.   Shi, J., Xue, Z., Tan, K.V., Yuan, H., Tsang, A.C.M., Tsao, S.W., Khong, P.-L. (2022) Longitudinal evaluation of five nasopharyngeal carcinoma animal models on the microPET/MR platform. European Journal of Nuclear Medicine and Molecular Imaging, 49(5), 1497-1507. doi:10.1007/s00259-021-05633-4

70.   Satalkar, V., Benassi, E., Mao, Y., Pan, X., Ran, C., Chen, X., Shao, Y. (2022) Computational investigation of substituent effects on the fluorescence wavelengths of oxyluciferin analogs. Journal of Photochemistry and Photobiology A: Chemistry, 431. doi:10.1016/j.jphotochem.2022.114018

71.   Gandomkar, Z., Khong, P.L., Punch, A., Lewis, S. (2022) Using Occlusion-Based Saliency Maps to Explain an Artificial Intelligence Tool in Lung Cancer Screening: Agreement Between Radiologists, Labels, and Visual Prompts. Journal of Digital Imaging, 35(5), 1164-1175. doi:10.1007/s10278-022-00631-w

72.   Lian, B.X., Ng, N.B.H., Wang, F., Nga, V.D.W., Tan, A.P., Lin, J. (2022) Diagnosis of hydrocephalus by cranial transillumination. Archives of Disease in Childhood: Fetal and Neonatal Edition, 107(5). doi:10.1136/archdischild-2021-322430

73.   Huang, Q., Chen, X., Meng, Q.-F., Yue, L., Jiang, W., Zhao, X.-Z., Rao, L., Chen, X., Chen, S. (2022) Microfluidics-Assisted Fluorescence Mapping of DNA Phosphorothioation. Analytical Chemistry, 94(29), 10479-10486. doi:10.1021/acs.analchem.2c01752

74.   Kee, T.P., Venkatanarasimha, N., Mohideen, S.M.H., Chan, L.L., Gogna, A., Schaefer, Liu, Q., Chen, X., Zhu, Z. (2022) Clinical Translational Research of Evans Blue Modified Peptides Used for Theranostics. Medical Journal of Peking Union Medical College Hospital, 13(2), 180-186. doi:10.12290/xhyxzz.2021-0764

75.   Feng, Y., Ding, D., Sun, W., Qiu, Y., Luo, L., Shi, T., Meng, S., Chen, X., Chen, H. (2022) Erratum: Magnetic Manganese Oxide Sweetgum-Ball Nanospheres with Large Mesopores Regulate Tumor Microenvironments for Enhanced Tumor Nanotheranostics. (ACS Applied Materials and Interfaces (2019) 11:41 (37461-37470) doi: 10.1021/acsami.9b11843) ACS Applied Materials and Interfaces, 14(32), 37257-37258. doi:10.1021/acsami.2c13260